EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Hidden findings: How often does Holmium laser enucleation of the prostate (HoLEP) uncover prostate cancer?

Suraj Pursnani, Sri Saran Manivasagam, Ernesto Mohr, Abdul-Jawad Majeed, Mandy Hsu, Elizabeth Zook, Noor Banihashem Ahmad, Joaquín Gurovich, Rodrigo Cañas, Erik B Lehman, Rodrigo Ledezma, Jay D Raman

International Urology and Nephrology · 2025

DOI: 10.1007/s11255-025-04769-8 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Urology and Nephrology, 2025. Verfasst von Suraj Pursnani und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Penn State College of Medicine, 500 University Dr., Hershey, PA, 17033, USA. Hauptthemen laut MEDLINE: Lasers, Solid-State, Prostatic Hyperplasia, Prostatic Neoplasms, Incidental Findings. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Penn State Department of Urology No Shave November Education and Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Benign prostatic hyperplasia (BPH) is a common condition with an increasing prevalence that parallels aging. Surgical procedures involving removal of the prostate can lead to detection of incidental prostate cancer (iPCa). Following holmium laser enucleation of the prostate (HoLEP), the incidence of such cases ranges from 5.6 to 23.3%. This study aims to provide a contemporary incidence of iPCa at HoLEP and associated risk factors.

Methods

A multi-national retrospective cohort analysis of 579 patients who underwent HoLEP between 2021 and 2024 was performed. Prior to HoLEP, MRI was performed in 115 (20%) patients, of which 19 were diagnosed with PCa via conventional biopsy and were excluded from analysis. Clinical, demographic, and radiologic parameters were queried to determine association with iPCa and rates of clinically significant prostate cancer (csPCa).

Results

Of 560 HoLEP patients, 39 (7.0%) were found to have de novo PCa, of which 13 (2.3%) had csPCa at the time of surgery. Patients with iPCa were more likely to be of white race (59% vs 29%, p < 0.001), ASA Grade 3/4 (41% vs 22%, p < 0.001), and higher preoperative mean PSA (5.7 vs 4 ng/dl, p = 0.007). On multivariate analysis, only white race (OR: 1.29, p = 0.04) and HoLEP morcellation time (OR: 0.91, p = 0.03) were associated with iPCa diagnosis.

Conclusions

In an international HoLEP cohort, de novo PCa was detected in 7.0% of patients, with only 2.3% harboring clinically significant (≥ GG2) disease. Higher proportions of white men, men with ASA 3/4, and higher preoperative mean PSA were observed in iPCa. These data are valuable for appropriate preoperative patient counseling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lasers, Solid-StateProstatic HyperplasiaProstatic NeoplasmsIncidental FindingsProstatectomyLaser TherapyHumansMaleRetrospective StudiesAgedMiddle AgedCohort Studies

Stichwörter der Autor:innen

Benign prostatic hyperplasiaClinically significant prostate cancerHoLEPIncidental prostate cancerRacial factors

Autor:innen und Institutionen

  • Department of Urology, Penn State College of Medicine, 500 University Dr., Hershey, PA, 17033, USA.
  • Department of Urology, Clinical Hospital of the University of Chile, Independencia, USA.
  • Department of Public Health Sciences, Penn State College of Medicine, 500 University Dr, Hershey, PA, 17033, USA.
  • Department of Urology, Penn State College of Medicine, 500 University Dr., Hershey, PA, 17033, USA. jraman@pennstatehealth.psu.edu.

Förderung

  • The Penn State Department of Urology No Shave November Education and Research Fund

Zitieren

APA

Pursnani, S., Manivasagam, S. S., Mohr, E., Majeed, A. J., Hsu, M., Zook, E., Ahmad, N. B., Gurovich, J., Cañas, R., Lehman, E. B., Ledezma, R., & Raman, J. D. (2025). Hidden findings: How often does Holmium laser enucleation of the prostate (HoLEP) uncover prostate cancer?. International Urology and Nephrology. https://doi.org/10.1007/s11255-025-04769-8

Vancouver

Pursnani S, Manivasagam SS, Mohr E, Majeed AJ, Hsu M, Zook E, et al. Hidden findings: How often does Holmium laser enucleation of the prostate (HoLEP) uncover prostate cancer?. International Urology and Nephrology. 2025. doi:10.1007/s11255-025-04769-8

BibTeX
@article{Pursnani2025,
  author = {Pursnani, Suraj and Manivasagam, Sri Saran and Mohr, Ernesto and Majeed, Abdul-Jawad and Hsu, Mandy and Zook, Elizabeth and Ahmad, Noor Banihashem and Gurovich, Joaquín and Cañas, Rodrigo and Lehman, Erik B and Ledezma, Rodrigo and Raman, Jay D},
  title = {Hidden findings: How often does Holmium laser enucleation of the prostate (HoLEP) uncover prostate cancer?},
  journal = {International Urology and Nephrology},
  year = {2025},
  doi = {10.1007/s11255-025-04769-8}
}
Kostenlos starten →